Rajasthan Board class 10th, 12th Results Date and Time Highlights: The Rajasthan Board of Secondary Education (RBSE) is set ...

Rein Therapeutics ("Rein") , a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, ...

Each winner received their framed winning design and a $50 check from the Barrio Neighborhood Planning Committee. Read more ...

Queensland billionaire Chris Wallin, the owner of QCoal Group, has increased his holding in junior explorer Venus Metals to ...

Detailed price information for Vox Royalty Corp (VOXR-T) from The Globe and Mail including charting and trades.

Trial is evaluating the safety, tolerability, and efficacy of LTI-03 in idiopathic pulmonary fibrosis (IPF) with topline interim data expected in the first half of ...

The Greenhaven Road Capital Main Fund returned approximately −12% net of fees and expenses in the first quarter. Click here ...

a first-in-class agonist antibody that activates macrophages by targeting dectin-2, and BDC-4182, a next-generation Boltbody™ Immune-Stimulating Antibody Conjugate (ISAC) clinical candidate targeting ...

DENVER, CO / ACCESS Newswire / May 22, 2025 / Vox Royalty Corp. (TSX:VOXR) (NASDAQ:VOXR) ("Vox" or the "Company"), a returns ...

Rein Therapeutics ("Rein") , a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, ...

Q1 2025 Earnings Call Transcript May 13, 2025 Exelixis, Inc. beats earnings expectations. Reported EPS is $0.55, expectations were $0.42. Operator: Good day, ladies and gentlemen, and welcome to the ...